|Title||An accurate semiautomated oscillometric blood pressure device for use in pregnancy (including pre-eclampsia) in a low-income and middle-income country population: the Microlife 3AS1-2.|
|Publication Type||Journal Article|
|Year of Publication||2015|
|Authors||Nathan, H, de Greeff, A, Hezelgrave, NL, Chappell, L, Shennan, A|
|Journal||Blood Press Monit|
|Date Published||2015 Feb|
|Keywords||Adult, Blood Pressure, Blood Pressure Determination, CRADLE, Developing Countries, Female, Global Health, Humans, Oscillometry, Poverty, Pre-Eclampsia, Pregnancy, South Africa, World Health Organization|
OBJECTIVES: To assess the accuracy of the Microlife 3AS1-2 blood pressure device in pregnancy and pre-eclampsia in a low-resource setting.
METHODS: Prospective validation according to the British Hypertension Society protocol. A total of 45 pregnant women were recruited from Kimberley Hospital (South Africa), of whom 15 had pre-eclampsia.
RESULTS: The Microlife 3AS1-2 device achieved an overall B/A grade in pregnancy (including pre-eclampsia), passing the British Hypertension Society protocol requirements and achieving the International Organization for Standardization standard with a mean difference and SD of -3.8 ± 7.3 and -1.5 ± 6.2 mmHg for systolic and diastolic pressures, respectively.
CONCLUSION: The Microlife 3AS1-2 device can be recommended for use in pregnancy, including pre-eclampsia. In addition, it fulfils the requirements stipulated by the WHO for an automated blood pressure device suitable for use in a low-resource setting. This makes it the ideal device for antenatal clinics and primary healthcare facilities in low-income and middle-income countries.
|Alternate Journal||Blood Press Monit|
|Grant List||DRF-2013-06-171 / / Department of Health / United Kingdom |
MR/N006240/1 / / Medical Research Council / United Kingdom
RP-2014-05-019 / / Department of Health / United Kingdom